Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products
Abstract
Authors
D Spurden PF Fogarty A Chhabra BJ Tortella J Alvir J Hodge M McDonald A Pleil
D Spurden PF Fogarty A Chhabra BJ Tortella J Alvir J Hodge M McDonald A Pleil
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now